Cargando…

Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer Patients

Nuclear factor erythroid 2-related factor 2 (NRF2) regulates cytoprotective antioxidant processes. In this study, the prognostic potential of NRF2 and its interactions with the estrogen receptor α (ERα) in ovarian cancer cells was investigated. NRF2 and ERα protein expression in ovarian cancer tissu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Czogalla, Bastian, Kahaly, Maja, Mayr, Doris, Schmoeckel, Elisa, Niesler, Beate, Kolben, Thomas, Burges, Alexander, Mahner, Sven, Jeschke, Udo, Trillsch, Fabian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337731/ https://www.ncbi.nlm.nih.gov/pubmed/30597961 http://dx.doi.org/10.3390/ijms20010112

Ejemplares similares

Correlation of NRF2 and progesterone receptor and its effects on ovarian cancer biology
por: Czogalla, Bastian, et al.
Publicado: (2019)

The Platelet-Activating Factor Receptor’s Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine
por: Deuster, Eileen, et al.
Publicado: (2021)

Nuclear Enolase-1/ MBP-1 expression and its association with the Wnt signaling in epithelial ovarian cancer
por: Czogalla, Bastian, et al.
Publicado: (2020)

The role of resveratrol, Sirtuin1 and RXRα as prognostic markers in ovarian cancer
por: Chen, Fangfang, et al.
Publicado: (2021)

Cytoplasmic VDR expression as an independent risk factor for ovarian cancer
por: Czogalla, Bastian, et al.
Publicado: (2020)

Correlation of the Aryl Hydrocarbon Receptor with FSHR in Ovarian Cancer Patients
por: Deuster, Eileen, et al.
Publicado: (2019)

AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin
por: Badmann, Susann, et al.
Publicado: (2022)

Galectin-8 and -9 as prognostic factors for cervical cancer
por: Beyer, Susanne, et al.
Publicado: (2022)

H3K4me3 Is a Potential Mediator for Antiproliferative Effects of Calcitriol (1α,25(OH)2D3) in Ovarian Cancer Biology
por: Han, Nan, et al.
Publicado: (2020)

PD-L1 expression and survival in p16-negative and -positive squamous cell carcinomas of the vulva
por: Czogalla, Bastian, et al.
Publicado: (2020)

Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway
por: Liao, Yue, et al.
Publicado: (2021)

Extracapsular Lymph Node Involvement in Ovarian Carcinoma
por: Heublein, Sabine, et al.
Publicado: (2019)

Subcellular Distribution of Thyroid Hormone Receptor Beta in Ovarian Cancer
por: Heublein, Sabine, et al.
Publicado: (2022)

Breast adipose tissue macrophages (BATMs) have a stronger correlation with breast cancer survival than breast tumor stroma macrophages (BTSMs)
por: Lin, Lili, et al.
Publicado: (2021)

Sirtuin1 expression and survival in endometrial and clear-cell uterine cancer
por: Beyer, Susanne, et al.
Publicado: (2020)

The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro
por: Han, Nan, et al.
Publicado: (2021)

M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis
por: Badmann, Susann, et al.
Publicado: (2020)

Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer
por: Reichenbach, Juliane, et al.
Publicado: (2023)

Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients
por: Ditsch, Nina, et al.
Publicado: (2020)

Actin Beta-Like 2 as a New Mediator of Proliferation and Migration in Epithelial Ovarian Cancer
por: Topalov, Nicole Elisabeth, et al.
Publicado: (2021)

PLA2G7/PAF-AH as Potential Negative Regulator of the Wnt Signaling Pathway Mediates Protective Effects in BRCA1 Mutant Breast Cancer
por: Liao, Yue, et al.
Publicado: (2023)

β-arrestin 2 Is a Prognostic Factor for Survival of Ovarian Cancer Patients Upregulating Cell Proliferation
por: Czogalla, Bastian, et al.
Publicado: (2020)

Protocol to optimize the biobanking of ovarian cancer organoids by accommodating patient-specific differences in stemness potential
por: Trillsch, Fabian, et al.
Publicado: (2023)

Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer
por: Kolben, Thomas, et al.
Publicado: (2022)

Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer
por: Heublein, Sabine, et al.
Publicado: (2019)

Carbonic anhydrase XII as biomarker and therapeutic target in ovarian carcinomas
por: Hiepp, Lisa, et al.
Publicado: (2022)

Expression pattern and prognostic potential of histamine receptors in epithelial ovarian cancer
por: Kraus, Fabian B. T., et al.
Publicado: (2022)

Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells
por: Kolben, Thomas, et al.
Publicado: (2022)

Potential of platinum-resensitization by Wnt signaling modulators as treatment approach for epithelial ovarian cancer
por: Kaltofen, Till, et al.
Publicado: (2020)

G Protein-Coupled Estrogen Receptor Correlates With Dkk2 Expression and Has Prognostic Impact in Ovarian Cancer Patients
por: Fraungruber, Patricia, et al.
Publicado: (2021)

High RIG-I and EFTUD2 expression predicts poor survival in endometrial cancer
por: Beyer, Susanne, et al.
Publicado: (2022)

First Evidence for a Role of Siglec-8 in Breast Cancer
por: Trebo, Anna, et al.
Publicado: (2021)

Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer
por: Vogelsang, Tilman L. R., et al.
Publicado: (2021)

Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9
por: Schulz, Heiko, et al.
Publicado: (2018)

Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients †
por: Schulz, Heiko, et al.
Publicado: (2017)

Expression of H3K4me3 and H3K9ac in breast cancer
por: Berger, Luisa, et al.
Publicado: (2020)

Diagnostic workup for endometrioid borderline ovarian tumors (eBOT) requires histopathological evaluation of the uterus
por: Reichenbach, Juliane, et al.
Publicado: (2021)

Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer Patients
por: Ansorge, Nadine, et al.
Publicado: (2021)

High Galectin-7 and Low Galectin-8 Expression and the Combination of both are Negative Prognosticators for Breast Cancer Patients
por: Trebo, Anna, et al.
Publicado: (2020)

EP3 receptor antagonist L798,106 reduces proliferation and migration of SK-BR-3 breast cancer cells
por: Hester, Anna, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cooah01ugo99le27fnad3k42fp